Skip to main content

Past Event
14 November 2011 - 15 November 2011

CBI’s 6th Annual Pharma/Biotech Device Corporate Tax Congress

CBI’s pharmaceutical tax conference addresses timely and relevant corporate tax matters impacting life science companies. Through a series of presentations, closed-door forums and industry-only dialogue, pharmaceutical and biotechnology corporate tax and transfer pricing professionals gain a comprehensive update on legislative developments, IRS rulings and tax planning opportunities.

Topics covered include:

  • Federal Legislation
  • Territorial Income
  • Industry Fees
  • Transfer Pricing
  • Supply Chain Tax Planning
  • Implications of UTP Disclosure
  • Codification of “Economic Substance”
  • R&D Credits
  • IRS Transfer Pricing Audits

John T. Hildy

For more information on this event and to register please, click here.

The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.